2022-10-27T05:57:33+03:00[Europe/Moscow] en true <p>type 1 &amp; 2 diabetes</p>, <p>regulate glucose metabolism, lower bg concentration by stimulating glucose uptake by muscle and fat, inhibit hepatic glucose production</p>, <p>d, e</p>, <p>a, b, c</p>, <p>lantus, lantus solostar, toujeo, basaglar, semglee</p>, <p>prophylaxis, type 2 diabetes</p>, <p>contraindications for empagliflozin</p>, <p>inhibits SGLT2; prevents glucose reabsorption from glomerulus </p>, <p>Jardiance </p>, <p>contraindications of insulin glargine</p>, <p>prophylaxis, obesity, type 2 diabetes</p>, <p>ozempic, rybelsus, wegovy</p>, <p>GLP-1 receptor agonist; stimulates insulin secretion; lowers glucagon secretion</p>, <p>c</p>, <p>contraindications of Semaglutide</p>, <p>type 2 diabetes</p>, <p>contraindications for Sitagliptin</p>, <p>DPP-4 enzyme inhibitor</p>, <p>Januvia</p>, <p>familial hypercholesterolemia, hyperlidemia </p>, <p>contraindications for rosuvastatin</p>, <p>selective inhibitor of HMG-CoA; catabolism of LDL</p>, <p>crestor, ezallor</p>, <p>hypercholesterolemia, hyerlipidemia, sitosterolemia </p>, <p>zetia</p>, <p>contraindications of ezetimibe</p>, <p>reduces blood cholesterol by inhibiting small intestinal absorption</p> flashcards
PPCP drugs weeks 8-11

PPCP drugs weeks 8-11

  • type 1 & 2 diabetes

    What are the indications for insulin glargine?

  • regulate glucose metabolism, lower bg concentration by stimulating glucose uptake by muscle and fat, inhibit hepatic glucose production

    MOA for insuline glargine?

  • d, e

    Which brands of insulin last 56 days upon opening?

    a. Basaglar

    b. KwikPen

    c. Lantus

    d. SoloStar

    e. Toujeo

  • a, b, c

    Which brands of insulin last 28 days upon opening?

    a. Basaglar

    b. KwikPen

    c. Lantus

    d. SoloStar

    e. Toujeo

  • lantus, lantus solostar, toujeo, basaglar, semglee

    what are the brand names for insulin glargine?

  • prophylaxis, type 2 diabetes

    What are the indications for empagliflozin?

  • contraindications for empagliflozin

    hypersensitivity, severe renal impairment, end-stage renal disease

  • inhibits SGLT2; prevents glucose reabsorption from glomerulus

    MOA for empagliflozin?

  • Jardiance

    Brand name for empagliflozin?

  • contraindications of insulin glargine

    hypersensitivity, hypoglycemia

  • prophylaxis, obesity, type 2 diabetes

    Indications for Semaglutide?

  • ozempic, rybelsus, wegovy

    brand names for Semaglutide?

  • GLP-1 receptor agonist; stimulates insulin secretion; lowers glucagon secretion

    MOA for Semaglutide?

  • c

    Which of the following is a Black Box warning for Semaglutide?

    a. hypertension

    b. hypoglycemia

    c. Risk of thyroid c-cell tumors

    d. Risk of thymus t-cell tumors

  • contraindications of Semaglutide

    hypersensitivity, pregnancy, breastfeeding

  • type 2 diabetes

    indications for Sitagliptin?

  • contraindications for Sitagliptin

     Pancreatic cancer, Pancreatitis, hypersensitivity

  • DPP-4 enzyme inhibitor

    MOA for Sitagliptin?

  • Januvia

    Brand name for Sitagliptin?

  • familial hypercholesterolemia, hyperlidemia

    Indications for rosuvastatin?

  • contraindications for rosuvastatin

    hypersensitivity, active liver disease, pregnancy or lactation

  • selective inhibitor of HMG-CoA; catabolism of LDL

    MOA for Rosuvastatin?

  • crestor, ezallor

    Brand names for Rosuvastatin?

  • hypercholesterolemia, hyerlipidemia, sitosterolemia

    indications for ezetimibe?

  • zetia

    Brand names for ezetimibe?

  • contraindications of ezetimibe

    hypersensitivity, concominant use with HMG-CoA statin in patients with liver disease, pregnancy, breastfeeding

  • reduces blood cholesterol by inhibiting small intestinal absorption

    MOA for ezetimibe?